Aloysius Romero Domingo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonic Disorders | 28 | 2022 | 321 | 6.840 |
Why?
|
| Genetic Diseases, X-Linked | 23 | 2022 | 375 | 4.860 |
Why?
|
| Dystonia | 5 | 2021 | 331 | 2.310 |
Why?
|
| Parkinsonian Disorders | 4 | 2020 | 265 | 1.040 |
Why?
|
| Transcription Factor TFIID | 5 | 2019 | 163 | 0.960 |
Why?
|
| TATA-Binding Protein Associated Factors | 5 | 2019 | 115 | 0.940 |
Why?
|
| Histone Acetyltransferases | 5 | 2019 | 359 | 0.850 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2021 | 1124 | 0.770 |
Why?
|
| Movement Disorders | 2 | 2020 | 428 | 0.740 |
Why?
|
| Myelin Sheath | 1 | 2021 | 650 | 0.650 |
Why?
|
| Parkinson Disease | 4 | 2018 | 2671 | 0.580 |
Why?
|
| Basal Ganglia Diseases | 4 | 2019 | 151 | 0.580 |
Why?
|
| Sequence Analysis | 1 | 2016 | 259 | 0.550 |
Why?
|
| Chromosomes, Human, X | 2 | 2015 | 311 | 0.500 |
Why?
|
| Agammaglobulinemia | 1 | 2014 | 177 | 0.480 |
Why?
|
| Mutation | 12 | 2021 | 29491 | 0.370 |
Why?
|
| Philippines | 4 | 2019 | 87 | 0.360 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2516 | 0.360 |
Why?
|
| Basal Ganglia | 3 | 2022 | 550 | 0.320 |
Why?
|
| Hearing Loss | 1 | 2014 | 714 | 0.320 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9804 | 0.320 |
Why?
|
| Nerve Degeneration | 3 | 2019 | 789 | 0.280 |
Why?
|
| Calcinosis | 3 | 2016 | 1456 | 0.220 |
Why?
|
| Genetic Variation | 1 | 2018 | 6664 | 0.220 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2021 | 6 | 0.210 |
Why?
|
| Corpus Striatum | 2 | 2018 | 1255 | 0.210 |
Why?
|
| Protein Kinases | 2 | 2018 | 1685 | 0.200 |
Why?
|
| Putamen | 2 | 2019 | 299 | 0.190 |
Why?
|
| Pedigree | 4 | 2016 | 4723 | 0.190 |
Why?
|
| Penetrance | 1 | 2021 | 359 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2021 | 1544 | 0.180 |
Why?
|
| DNA Repeat Expansion | 1 | 2019 | 63 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17432 | 0.180 |
Why?
|
| Molecular Chaperones | 2 | 2021 | 759 | 0.180 |
Why?
|
| Disease Progression | 2 | 2017 | 13308 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2018 | 1884 | 0.170 |
Why?
|
| Globus Pallidus | 1 | 2019 | 246 | 0.160 |
Why?
|
| Ocular Motility Disorders | 1 | 2018 | 142 | 0.160 |
Why?
|
| Striatonigral Degeneration | 1 | 2016 | 13 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 814 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 958 | 0.160 |
Why?
|
| Tubulin | 2 | 2018 | 760 | 0.150 |
Why?
|
| Hemiplegia | 1 | 2016 | 142 | 0.150 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 138 | 0.140 |
Why?
|
| Evoked Potentials | 2 | 2018 | 1042 | 0.140 |
Why?
|
| Substantia Nigra | 1 | 2017 | 359 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 381 | 0.130 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 305 | 0.130 |
Why?
|
| Humans | 39 | 2022 | 717280 | 0.130 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 242 | 0.130 |
Why?
|
| Genetic Loci | 2 | 2021 | 2614 | 0.120 |
Why?
|
| Torticollis | 1 | 2014 | 67 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 96 | 0.120 |
Why?
|
| Alleles | 2 | 2021 | 7101 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2013 | 256 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 237 | 0.110 |
Why?
|
| Turner Syndrome | 1 | 2013 | 127 | 0.110 |
Why?
|
| Haplotypes | 2 | 2018 | 2883 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 684 | 0.110 |
Why?
|
| Phenotype | 6 | 2022 | 16404 | 0.110 |
Why?
|
| Family Health | 1 | 2016 | 1287 | 0.110 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2721 | 0.100 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 682 | 0.100 |
Why?
|
| Cerebellum | 1 | 2018 | 1490 | 0.100 |
Why?
|
| Neural Inhibition | 1 | 2015 | 592 | 0.100 |
Why?
|
| Data Collection | 1 | 2020 | 3314 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 1604 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1338 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1944 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 2065 | 0.090 |
Why?
|
| Middle Aged | 19 | 2021 | 215054 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1851 | 0.090 |
Why?
|
| Genotype | 2 | 2021 | 12923 | 0.090 |
Why?
|
| Male | 24 | 2021 | 351399 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2063 | 0.080 |
Why?
|
| Motor Cortex | 1 | 2015 | 963 | 0.080 |
Why?
|
| Adult | 19 | 2021 | 212470 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1730 | 0.080 |
Why?
|
| Age of Onset | 3 | 2021 | 3333 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2017 | 3030 | 0.070 |
Why?
|
| Serbia | 2 | 2016 | 16 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4825 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2015 | 1317 | 0.070 |
Why?
|
| Germany | 2 | 2019 | 837 | 0.070 |
Why?
|
| Atrophy | 2 | 2019 | 1509 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2014 | 3340 | 0.060 |
Why?
|
| Aged | 7 | 2021 | 162862 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4472 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 5728 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4352 | 0.060 |
Why?
|
| Case-Control Studies | 5 | 2021 | 21811 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5948 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3848 | 0.060 |
Why?
|
| Genes, sis | 1 | 2021 | 3 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3990 | 0.060 |
Why?
|
| Reaction Time | 2 | 2018 | 2138 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2018 | 2300 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 34503 | 0.050 |
Why?
|
| Young Adult | 5 | 2021 | 56249 | 0.050 |
Why?
|
| Sex Factors | 1 | 2014 | 10661 | 0.050 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2018 | 36 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2018 | 5848 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 409 | 0.040 |
Why?
|
| Female | 14 | 2019 | 377934 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 103 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 156 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 402 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2018 | 242 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 2018 | 188 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4312 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2018 | 252 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 296 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 81128 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 16020 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2017 | 357 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 1016 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2794 | 0.030 |
Why?
|
| Brain Waves | 1 | 2018 | 394 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 170894 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 185 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1245 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1594 | 0.030 |
Why?
|
| Serine | 1 | 2016 | 857 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 13301 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1134 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2018 | 6561 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 959 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 1379 | 0.030 |
Why?
|
| Iron | 1 | 2019 | 1737 | 0.030 |
Why?
|
| Brain | 4 | 2021 | 25281 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 899 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1367 | 0.020 |
Why?
|
| Transfection | 1 | 2018 | 6142 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 9000 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6529 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1836 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3514 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5980 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3105 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 13317 | 0.020 |
Why?
|
| Affect | 1 | 2014 | 1504 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 8013 | 0.020 |
Why?
|
| Child | 3 | 2021 | 74388 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 11276 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 85143 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3698 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 39891 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4594 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2674 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 11951 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 20097 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 14243 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15600 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18738 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9442 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 15258 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39302 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6109 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18353 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20435 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58528 | 0.010 |
Why?
|